Home › Companies › BEAM THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and BEAM THERAPEUTICS INC.’s Form 8-K, filed June 10, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 5, 2024: 3 items on BEAM THERAPEUTICS INC.’s Form 8-K, filed June 10, 2024: 2 approved · 1 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore BEAM THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are BEAM THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 10, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Graham Cooper | 49,482,793 | 6,520,772 | 1,838,647 | -- | 8,424,668 | 88% | Not verified | — |
| 2. Appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2024 | 66,048,930 | 176,166 | 41,784 | -- | -- | 99.7% | Approved | — |
| 3. Compensation of the Company's named executive officers | 56,501,513 | 1,295,311 | 45,388 | -- | 8,424,668 | 98% | Approved | — |
This meeting is also recorded here as June 6, 2024; both records come from the same filing, so the date should be checked against it.
Source: BEAM THERAPEUTICS INC., Form 8-K, filed with the SEC on June 10, 2024 — read the filing on EDGAR.
Each item below shows how the 263 asset managers that disclosed a BEAM THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Description as filed by funds: Election of the following nominee as a Class I Director for a three-year term ending at our Annual Meeting of Stockholders to be held in 2027: Graham Cooper
BEAM THERAPEUTICS INC.’s own tally for this item (“Elect Director: Graham Cooper”): 49,482,793 for, 6,520,772 against, per its Form 8-K filed June 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 63 asset managers below reported 23,694,238 for, 1,048,788 against, 13,077 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 7,681,910 | 0 | 0 | 0 | For |
| Vanguard | 7,487,514 | 0 | 0 | 0 | For |
| Fidelity | 2,759,135 | 0 | 0 | 0 | For |
| BlackRock | 1,804,526 | 0 | 0 | 0 | For |
| State Street | 1,164,068 | 16,888 | 0 | 0 | For |
| T. Rowe Price | 1,005,154 | 0 | 0 | 0 | For |
| Charles Schwab | 580,439 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 211,109 | 0 | 0 | 0 | For |
| TIAA | 172,527 | 0 | 0 | 0 | For |
| Global X | 155,404 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 139,813 | 0 | 0 | Against |
| OLD WESTBURY FUNDS INC | 0 | 129,469 | 0 | 0 | Against |
| First Trust | 0 | 118,821 | 0 | 0 | Against |
| Equitable | 28,330 | 85,310 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 111,525 | 0 | 0 | 0 | For |
| Dimensional | 0 | 100,098 | 0 | 0 | Against |
| Russell Investments | 95,459 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 85,199 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 79,885 | 0 | 0 | Against |
| American Century | 0 | 74,299 | 0 | 0 | Against |
| Lincoln Financial | 59,800 | 5,835 | 0 | 0 | Mixed |
| John Hancock | 36,100 | 27,300 | 0 | 0 | Mixed |
| ProShares | 0 | 54,921 | 0 | 0 | Against |
| Pacific Life | 50,287 | 0 | 0 | 0 | For |
| Morgan Stanley | 46,530 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.
Combines 10 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: Approve, on an advisory basis, the compensation of our named executive officers.
BEAM THERAPEUTICS INC.’s own tally for this item (“3. Compensation of the Company's named executive officers”): 56,501,513 for, 1,295,311 against — passed, per its Form 8-K filed June 10, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 – The compensation of the Company's named executive officers was approved, on an advisory basis, based on the following votes:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 7,681,910 | 0 | 0 | 0 | For |
| Vanguard | 7,487,514 | 0 | 0 | 0 | For |
| Fidelity | 2,759,135 | 0 | 0 | 0 | For |
| BlackRock | 1,804,526 | 0 | 0 | 0 | For |
| State Street | 1,176,191 | 4,765 | 0 | 0 | For |
| T. Rowe Price | 1,005,154 | 0 | 0 | 0 | For |
| Charles Schwab | 580,439 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 211,109 | 0 | 0 | 0 | For |
| TIAA | 172,527 | 0 | 0 | 0 | For |
| Global X | 155,404 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 139,813 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 129,469 | 0 | 0 | 0 | For |
| First Trust | 118,821 | 0 | 0 | 0 | For |
| Equitable | 113,640 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 111,525 | 0 | 0 | 0 | For |
| Dimensional | 100,098 | 0 | 0 | 0 | For |
| Russell Investments | 95,459 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 85,199 | 0 | 0 | 0 | For |
| Goldman Sachs | 79,885 | 0 | 0 | 0 | For |
| American Century | 0 | 74,299 | 0 | 0 | Against |
| Lincoln Financial | 65,635 | 0 | 0 | 0 | For |
| John Hancock | 63,400 | 0 | 0 | 0 | For |
| ProShares | 54,921 | 0 | 0 | 0 | For |
| Pacific Life | 50,287 | 0 | 0 | 0 | For |
| Morgan Stanley | 46,530 | 0 | 0 | 0 | For |
Fund voting reports, all 61 managers: 24,647,728 for, 95,270 against, 13,077 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARCH Venture Management, LLC | 5,443,039 | 0 | 0 | 0 | For |
| FARALLON CAPITAL MANAGEMENT LLC | 3,516,479 | 0 | 0 | 0 | For |
| Fidelity | 3,060,927 | 0 | 0 | 0 | For |
| State Street | 2,269,998 | 25,601 | 0 | 0 | For |
| BlackRock | 2,146,077 | 20,873 | 0 | 0 | For |
| Nikko Asset Management Americas, Inc. | 2,028,101 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 1,879,617 | 0 | 0 | 0 | For |
| Temasek Holdings (Private) Ltd | 1,812,972 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,273,512 | 0 | 0 | 0 | For |
| Impresa Management LLC | 1,139,443 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 872,600 | 0 | 0 | 0 | For |
| Charles Schwab | 580,550 | 0 | 0 | 0 | For |
| Yiheng Capital Management, L.P. | 505,100 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD & CO LTD | 446,964 | 0 | 0 | 0 | For |
| JPMorgan | 417,442 | 0 | 0 | 0 | For |
| Northern Trust | 372,313 | 49 | 0 | 0 | For |
| Nikko Asset Management Co., Ltd. | 329,950 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 273,115 | 0 | 0 | 0 | For |
| Vanguard | 197,592 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 190,474 | 0 | 0 | 0 | For |
| Nuveen | 174,191 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 143,748 | 0 | 0 | Against |
| Rafferty Asset Management, LLC | 139,813 | 0 | 0 | 0 | For |
| BESSEMER INVESTMENT MANAGEMENT LLC | 129,469 | 0 | 0 | 0 | For |
| UBS | 0 | 114,876 | 0 | 0 | Against |
Institutional-manager reports, all 219 managers: 30,729,593 for, 571,071 against, 90 abstained, 1,632 not voted. Showing the 25 largest; see all in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.7% Approved · of votes cast
Description as filed by funds: Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024.
BEAM THERAPEUTICS INC.’s own tally for this item (“2. Appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2024”): 66,048,930 for, 176,166 against — passed, per its Form 8-K filed June 10, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 – The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2024 was ratified, based on the following votes:”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 63 asset managers below reported 24,743,026 for, 13,077 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 7,681,910 | 0 | 0 | 0 | For |
| Vanguard | 7,487,514 | 0 | 0 | 0 | For |
| Fidelity | 2,759,135 | 0 | 0 | 0 | For |
| BlackRock | 1,804,526 | 0 | 0 | 0 | For |
| State Street | 1,180,956 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,005,154 | 0 | 0 | 0 | For |
| Charles Schwab | 580,439 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 211,109 | 0 | 0 | 0 | For |
| TIAA | 172,527 | 0 | 0 | 0 | For |
| Global X | 155,404 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 139,813 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 129,469 | 0 | 0 | 0 | For |
| First Trust | 118,821 | 0 | 0 | 0 | For |
| Equitable | 113,640 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 111,525 | 0 | 0 | 0 | For |
| Dimensional | 100,098 | 0 | 0 | 0 | For |
| Russell Investments | 95,459 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 85,199 | 0 | 0 | 0 | For |
| Goldman Sachs | 79,885 | 0 | 0 | 0 | For |
| American Century | 74,299 | 0 | 0 | 0 | For |
| Lincoln Financial | 65,635 | 0 | 0 | 0 | For |
| John Hancock | 63,400 | 0 | 0 | 0 | For |
| ProShares | 54,921 | 0 | 0 | 0 | For |
| Pacific Life | 50,287 | 0 | 0 | 0 | For |
| Morgan Stanley | 46,530 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 82,280,827 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | ARK ETF Trust | 9.34% |
| 2 | Vanguard | 9.10% |
| 3 | Fidelity | 3.35% |
| 4 | BlackRock | 2.19% |
| 5 | State Street | 1.44% |
| 6 | T. Rowe Price | 1.22% |
| 7 | Charles Schwab | 0.71% |
| 8 | Columbia Threadneedle | 0.26% |
| 9 | TIAA | 0.21% |
| 10 | Global X | 0.19% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | ARCH Venture Management, LLC | 6.62% |
| 2 | FARALLON CAPITAL MANAGEMENT LLC | 4.27% |
| 3 | Fidelity | 3.72% |
| 4 | State Street | 2.79% |
| 5 | BlackRock | 2.63% |
| 6 | Nikko Asset Management Americas, Inc. | 2.46% |
| 7 | Redmile Group, LLC | 2.28% |
| 8 | Temasek Holdings (Private) Ltd | 2.20% |
| 9 | T. Rowe Price | 1.55% |
| 10 | Impresa Management LLC | 1.38% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| FMR (Fidelity) | 14.21% | 13F |
| ARK Investment Management LLC | 11.42% | 13G |
| Vanguard Group | 11.24% | 13F |
| FMR LLC and affiliates | 10.88% | DEF14A |
| BlackRock | 9.90% | 13F |
| Funds affiliated with ARCH Venture Partners | 6.62% | DEF14A |
| Farallon Capital Partners and affiliates | 4.99% | DEF14A |
| State Street | 4.53% | 13F |
| John Evans | 2.16% | DEF14A |
| Geode Capital | 1.99% | 13F |
Percentages above are of 82,280,827 shares outstanding, as reported by BEAM THERAPEUTICS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BEAM THERAPEUTICS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At BEAM THERAPEUTICS INC.'s shareholder meeting held June 5, 2024, in the 2023-2024 proxy season, 263 asset managers reported how they voted on 3 ballot items in their SEC Form N-PX filings, covering 1,023 separate fund positions. On the most widely held item on that ballot — Approve, on an advisory basis, the compensation of our named executive officers. — BEAM THERAPEUTICS INC.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: BEAM THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 10, 2024.
BEAM THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.